Effects of Lithium and Divalproex'on Brain-Derived Neurotrophic Factor in Huntington's Disease

NCT00095355 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

35

Enrollment

NIH

Sponsor class

Conditions

Huntington's Disease

Interventions

DRUG: Lithium
DRUG: Divalproex

Sponsor

National Institute of Neurological Disorders and Stroke (NINDS)